Compare Tata Chemicals with Similar Stocks
Dashboard
Weak Long Term Fundamental Strength with a -14.18% CAGR growth in Operating Profits over the last 5 years
- The company has been able to generate a Return on Equity (avg) of 5.13% signifying low profitability per unit of shareholders funds
The company has declared Negative results for the last 3 consecutive quarters
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Commodity Chemicals
INR 17,400 Cr (Small Cap)
NA (Loss Making)
67
1.66%
0.32
0.18%
0.80
Total Returns (Price + Dividend) 
Latest dividend: 11 per share ex-dividend date: Jun-10-2026
Risk Adjusted Returns v/s 
Returns Beta
News

Tata Chemicals Ltd. is Rated Strong Sell
Tata Chemicals Ltd. is rated Strong Sell by MarketsMOJO, with this rating last updated on 09 June 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 04 August 2026, providing investors with the latest insights into the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read full news articleAre Tata Chemicals Ltd. latest results good or bad?
Tata Chemicals Ltd. has reported its financial results for the first quarter of FY27, revealing a complex operational landscape. The company achieved net sales of ₹4,255 crores, marking a significant year-on-year growth of 14.41%. This performance represents the highest quarterly revenue in its history, indicating a robust top-line expansion. However, this growth contrasts sharply with the company's bottom-line performance, as it posted a consolidated net loss of ₹17 crores, a stark decline from a profit of ₹252 crores in the same quarter last year. This shift highlights a critical profitability crisis, despite the revenue growth. The operating margin for the quarter was recorded at 13.04%, which reflects a contraction of 4.41 percentage points compared to the previous year. This decline in margins can be attributed to rising input costs and unfavorable pricing dynamics, particularly in the soda ash and so...
Read full news article
Tata Chemicals Q1 FY27: Losses Deepen as Margin Pressures Mount Despite Revenue Growth
Tata Chemicals Ltd. reported a consolidated net loss of ₹17.00 crores for Q1 FY27 ended June 2026, marking a dramatic reversal from a profit of ₹252.00 crores in the year-ago quarter. The loss represents a staggering 106.75% year-on-year decline and a 99.20% sequential deterioration from the previous quarter's loss of ₹2,132.00 crores. The stock, trading at ₹680.50 with a market capitalisation of ₹17,336.16 crores, has declined 2.59% following the results announcement, extending its brutal 27.14% decline over the past twelve months.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
03-Aug-2026 | Source : BSETranscript of Analysts/Investor Call pertaining to the Financial results for the quarter ended June 30 2026.
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
29-Jul-2026 | Source : BSEPlease find enclosed intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
29-Jul-2026 | Source : BSEPlease find enclosed ESG Rating assigned by SES ESG Research Private Limited
Corporate Actions 
No Upcoming Board Meetings
Tata Chemicals Ltd. has declared 110% dividend, ex-date: 10 Jun 26
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 35 Schemes (9.68%)
Held by 150 FIIs (12.07%)
Tata Sons Private Limited (31.9%)
Life Insurance Corporation Of India - P & Gs Fund (9.24%)
24.12%
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
QoQ Growth in quarter ended Jun 2026 is 23.76% vs -3.15% in Mar 2026
QoQ Growth in quarter ended Jun 2026 is 99.20% vs -2,192.47% in Mar 2026
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -2.47% vs -5.21% in Sep 2024
Growth in half year ended Sep 2025 is -4.36% vs -64.17% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -2.04% vs -4.75% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -18.90% vs -73.97% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -2.04% vs -3.46% in Mar 2025
YoY Growth in year ended Mar 2026 is -906.81% vs -12.31% in Mar 2025






